These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9441425)

  • 1. [Palliative treatment with cytostatics of metastatic colorectal cancer in general practice. A model].
    Skylstad D; Sørbye H; Småland R
    Tidsskr Nor Laegeforen; 1997 Nov; 117(27):3969-72. PubMed ID: 9441425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic palliative chemotherapy with 5-fluorouracil and leucovorin in disseminated colorectal cancer].
    Wiboltt K; Raskov HH
    Ugeskr Laeger; 1999 Jun; 161(25):3827-32. PubMed ID: 10412300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with cytostatic agents should be considered in colorectal cancer. It improves prognosis and quality of life].
    Larsson PA
    Lakartidningen; 1999 May; 96(19):2314-6. PubMed ID: 10377671
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug clinics. How I treat. II. Therapeutic approaches to metastatic colorectal cancer].
    Jerusalem G; Bours V; Fillet G
    Rev Med Liege; 1998 Jun; 53(6):318-21. PubMed ID: 9713208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Palliative chemotherapy in colorectal cancer--can we afford it?].
    Kronborg O
    Ugeskr Laeger; 1999 Jun; 161(25):3815. PubMed ID: 10412296
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial.
    Behr TM; Memtsoudis S; Vougioukas V; Liersch T; Gratz S; Schmidt F; Lorf T; Post S; Wörmann B; Hiddemann W; Ringe B; Becker W
    Anticancer Res; 1999; 19(4A):2427-32. PubMed ID: 10470170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant and palliative treatment of colorectal cancer with fluorinated pyrimidines. A pharmacological and clinical review.
    Gustavsson B; Hafström L
    Acta Chir Scand Suppl; 1981; 504():1-28. PubMed ID: 6176091
    [No Abstract]   [Full Text] [Related]  

  • 9. [A gastroenterology unit experience with adjuvant chemotherapy for non-metastatic colon cancer: results from 24 cases].
    Belhadj N; Gargouri D; Kharrat J; Ben Hriz F; Kochlef A; Kilani A; Romani M; Ghorbel A; Cherif R; Khlifi S; Ben Maamer A; Letaief A
    Tunis Med; 2003 Jun; 81(6):395-9. PubMed ID: 14534945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer.
    Cure H; Chevalier V; Pezet D; Bousquet J; Focan C; Levi F; Garufi C; Chipponi J; Chollet P
    Anticancer Res; 2000; 20(6C):4649-53. PubMed ID: 11205195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial.
    Hamaguchi T; Shirao K; Yamamichi N; Hyodo I; Koizumi W; Seki S; Imamura T; Honma H; Ohtsu A; Boku N; Mukai T; Yamamoto S; Fukuda H; Yoshida S;
    Jpn J Clin Oncol; 2008 Jun; 38(6):432-7. PubMed ID: 18515821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).
    Jung KH; Kil SY; Choi IK; Seo JH; Shin C; Kim YS; Kim JH
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1181-2. PubMed ID: 17044215
    [No Abstract]   [Full Text] [Related]  

  • 14. Resection of hepatic metastasis after 5-fluorouracil and cofactor for colon cancer.
    Costantini CL; Reid TR; Bouvet M
    Hepatogastroenterology; 2009; 56(91-92):645-9. PubMed ID: 19621672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial comparing weekly bolus 5-fluorouracil plus leucovorin versus monthly 5-day 5-fluorouracil plus leucovorin in metastatic colorectal cancer.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Chen PM
    Hepatogastroenterology; 2000; 47(36):1599-603. PubMed ID: 11149011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
    Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
    Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-fluorouracil and leucovorin as second-line chemotherapy in carcinomas of unknown primary site.
    Culine S; Ychou M; Fabbro M; Romieu G; Cupissol D
    Anticancer Res; 2001; 21(2B):1455-7. PubMed ID: 11396231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.
    Burch PA; Block M; Schroeder G; Kugler JW; Sargent DJ; Braich TA; Mailliard JA; Michalak JC; Hatfield AK; Wright K; Kuross SA
    Clin Cancer Res; 2000 Sep; 6(9):3486-92. PubMed ID: 10999733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
    Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical practice guideline: 2003 update of Standards, Options et Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report)].
    Conroy T; Gory-Delabaere G; Adenis A; Bosquet L; Bouché O; Louvet C; Mitry E; Bécouarn Y; Bosset JF; Ducreux M; Etienne PL; Merrouche Y; Monges G; Rougier P; ; ; ; ; ; ; ;
    Bull Cancer; 2004 Oct; 91(10):759-68. PubMed ID: 15556876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.